Pyxis Oncology, Inc. (PYXS) Financials

PYXS Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 54.9 million 43.5 million
March 31, 2026 64.3 million 33.0 million
Dec. 31, 2025 91.5 million 38.1 million
Sept. 30, 2025 105.6 million 36.8 million

PYXS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -18.2 million 5.5 million
March 31, 2026 -26.0 million 1.2 million
Dec. 31, 2025 -10.4 million 2.1 million
Sept. 30, 2025 -13.3 million 3.1 million

PYXS Net Income

No data available :(

PYXS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 33.0 million - 16.0 million
March 31, 2026 42.5 million - 16.5 million
Dec. 31, 2025 66.9 million - 18.7 million
Sept. 30, 2025 76.3 million - 19.1 million

PYXS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 64.0 million
March 31, 2026 63.5 million
Dec. 31, 2025 62.1 million
Sept. 30, 2025 62.6 million

PYXS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 16.1 million 9.9 million -
March 31, 2026 - 19.6 million 4.4 million -
Dec. 31, 2025 - 21.7 million 5.2 million -
Sept. 30, 2025 9000 17.8 million 5.0 million -684000

PYXS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 459000
Dec. 31, 2025 11.0 million -432000
Sept. 30, 2025 - -

PYXS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PYXS

Price: $3.21

52 week price:
1.03
5.55

Earnings Per Share: -1.35 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 10300

Market Capitalization: 246.5 million

Links: